A Euglycemic Insulin Clamp Study in Type 1 Diabetic Patients With Oral Insulin (ORAMED)

NCT02535715 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: ORMD-0801 capsules- 2x8mg
DRUG: ORMD-0801 capsules- 3x8mg
DRUG: ORMD-0801 capsules- 1x16mg

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

[object Object]